Table TDI-21. Gender ratio (ratio of males to females) among new and all clients entering outpatient treatment by primary drug (opioids, cannabis, cocaine, other stimulants) in 2004 for countries providing data – Part (i) Among new clients entering outpatient treatment

Country

 

Opioids

Cocaine

Stimulants

Hypnotics, sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other drugs

Base (known status)

Czech Republic

 

3.1

1.0

1.7

0.8

6.0

7.3

3.2

1.0

1054

Denmark

(1)

4.1

3.0

2.1

0.5

 

 

3.9

1.9

1143

Germany

 

3.7

6.4

2.7

0.6

2.4

2.3

6.2

5.3

13204

Greece

(2)

6.1

5.3

3.5

12.0

 

 

4.7

1.0

1221

Italy

(3)

6.2

15.3

4.8

2.5

 

5.0

13.7

2.0

24768

Cyprus

(4)

8.9

2.0

3.0

 

 

 

17.3

 

164

Hungary

 

3.0

11.3

1.2

0.4

3.3

2.4

7.6

1.8

4398

Malta

(5)

3.8

7.5

7.0

 

 

 

 

 

147

Netherlands

 

3.4

4.7

2.1

1.1

0.8

2.0

4.0

0.6

4785

Slovenia

(6)

3.1

4.0

1.0

 

 

 

3.4

 

521

Slovakia

(7)

2.3

 

5.8

0.5

3.0

41.0

7.3

0.5

306

Finland

(8)

1.5

 

1.3

4.3

 

 

2.6

 

445

Sweden

(9)

0.8

2.2

1.2

0.6

 

1.0

47.2

 

826

United Kingdom

 

2.4

3.1

1.8

1.4

4.2

1.6

3.7

3.0

26990

Bulgaria

(10)

4.8

 

1.0

 

 

 

2.3

 

442

Romania

(11)

4.1

 

0.8

 

 

 

4.7

 

709

 

 

 

 

 

 

 

 

 

 

 

Total

 

3.5

5.8

2.1

0.9

2.0

2.9

6.0

2.2

 

 

 

 

 

 

 

 

 

 

 

 

Total base

 

35421

10176

5311

1878

190

506

24837

2804

81123

Notes:

(1) No cases for hallucinogens and volatile inhalants.

(2) No female cases for hallucinogens and volatile inhalants.

(3) No female cases for hallucinogens.

(4) No male cases for hypnotics; no female cases for hallucinogens; no cases for volatile inhalants and other drugs.

(5) No cases for hallucinogens, volatile inhalants and other drugs.

(6) No female cases for hypnotics; no cases for hallucinogens, volatile inhalants and other drugs.

(7) No female cases for cocaine; ratio for volatiles: 41 men/1 woman.

(8) No cases for cocaine; no female cases for volatiles; no male cases for hallucinogens and other drugs.

(9) No female cases for hallucinogens and other drugs; 283 men and 6 women only were reported for cannabis use.

(10) No cases for cocaine, hallucinogens, other drugs; no female cases for volatiles; 2 female cases for hypnotics but no male cases.

(11) Information on outpatient treatment centres was included in the Inpatient treatment centres file that was sent in 2004.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab21a-en.xml